CN102741696A - 阿尔茨海默病外周细胞中pkc同工酶加工的异常改变 - Google Patents

阿尔茨海默病外周细胞中pkc同工酶加工的异常改变 Download PDF

Info

Publication number
CN102741696A
CN102741696A CN2010800551432A CN201080055143A CN102741696A CN 102741696 A CN102741696 A CN 102741696A CN 2010800551432 A CN2010800551432 A CN 2010800551432A CN 201080055143 A CN201080055143 A CN 201080055143A CN 102741696 A CN102741696 A CN 102741696A
Authority
CN
China
Prior art keywords
pkc
cells
isozyme
index
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800551432A
Other languages
English (en)
Chinese (zh)
Inventor
T·K·卡恩
D·L·阿尔康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blanchette Rockefeller Neurosciences Institute
Original Assignee
Blanchette Rockefeller Neurosciences Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blanchette Rockefeller Neurosciences Institute filed Critical Blanchette Rockefeller Neurosciences Institute
Publication of CN102741696A publication Critical patent/CN102741696A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2010800551432A 2009-10-02 2010-10-01 阿尔茨海默病外周细胞中pkc同工酶加工的异常改变 Pending CN102741696A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24836109P 2009-10-02 2009-10-02
US61/248,361 2009-10-02
PCT/US2010/051112 WO2011041670A2 (en) 2009-10-02 2010-10-01 Abnormal alterations of pkc isozymes processing in alzheimer's disease peripheral cells

Publications (1)

Publication Number Publication Date
CN102741696A true CN102741696A (zh) 2012-10-17

Family

ID=43302691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800551432A Pending CN102741696A (zh) 2009-10-02 2010-10-01 阿尔茨海默病外周细胞中pkc同工酶加工的异常改变

Country Status (7)

Country Link
US (1) US20110212474A1 (cg-RX-API-DMAC7.html)
EP (1) EP2483695A2 (cg-RX-API-DMAC7.html)
JP (2) JP6013184B2 (cg-RX-API-DMAC7.html)
CN (1) CN102741696A (cg-RX-API-DMAC7.html)
BR (1) BR112012007557A2 (cg-RX-API-DMAC7.html)
CA (1) CA2776498A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011041670A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115078570A (zh) * 2022-05-30 2022-09-20 郑州大学第一附属医院 Tau蛋白639位硫氰酸氨基酸修饰在快速质谱法检测阿尔茨海默症中的应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014145316A1 (en) * 2013-03-15 2014-09-18 Alkon Daniel L Methods for identifying neuroprotective pkc activators
EP3265810A1 (en) 2015-03-06 2018-01-10 Blanchette Rockefeller Neurosciences, Institute Methods for classifying populations including alzheimer's disease populations
US20190041404A1 (en) * 2016-02-22 2019-02-07 The West Virginia University Board Of Governors On Behalf Of West Virginia University Diagnosing mild cognitive impairment (mci), predicting alzheimer's disease (ad) dementia onset, and screening and monitoring agents for treating mci or preventing dementia onset
US20180282784A1 (en) * 2017-03-31 2018-10-04 NeuroDiagnostics LLC LYMPHOCYTE-BASED PKCe TEST FOR ALZHEIMER'S DISEASE

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107050A (en) * 1993-05-03 2000-08-22 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic test for alzheimers disease
CN1795158A (zh) * 2003-05-30 2006-06-28 因德纳有限公司 可用于治疗阿尔茨海默病的化合物和含有它们的制剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080784A (en) * 1986-06-11 2000-06-27 Procyon Pharmaceuticals, Inc. Protein kinase C modulators N
US5385915A (en) * 1990-05-16 1995-01-31 The Rockefeller University Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
US20030108956A1 (en) * 1993-05-03 2003-06-12 Alkon Daniel L. Cell tests for Alzheimer's disease
US5976816A (en) * 1993-05-03 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Cell tests for alzheimer's disease
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
AU2316797A (en) * 1996-02-29 1997-09-16 Mount Sinai Hospital Corporation Shc proteins
AU1630501A (en) * 1999-10-08 2001-04-23 Superarray, Inc. Compositions and methods for detecting protein modification and enzymatic activity
AUPR215700A0 (en) * 2000-12-19 2001-01-25 Fujisawa Pharmaceutical Co., Ltd. Carboxylic acid compound having cyclopropane ring
WO2002063005A2 (en) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Lipid-associated molecules
ES2305234T3 (es) * 2001-02-27 2008-11-01 Blanchette Rockefeller Neurosciences Institute Diagnostico de la enfermedad de alzheimer basado en la fosforilacion de una proteina quinosa activada por mitogeno.
US20040014678A1 (en) * 2001-08-08 2004-01-22 Antonella Favit Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytoc pathway
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US6897014B2 (en) 2002-02-15 2005-05-24 Fuji Photo Film Co., Ltd. Silver halide photographic light-sensitive material, photographic emulsion, and mercapto group-containing polymer compound used for them
KR100574017B1 (ko) 2003-08-11 2006-04-26 삼성전자주식회사 잉크젯 프린터의 잉크 카트리지
KR101332540B1 (ko) 2005-05-27 2013-11-22 칼 짜이스 에스엠테 게엠베하 광산란 디스크, 그 사용 및 파면 측정 장치
US20070054890A1 (en) * 2005-07-29 2007-03-08 Alkon Daniel L Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
WO2007044094A1 (en) * 2005-10-11 2007-04-19 Blanchette Rockefeller Neurosciences Institute Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
US7595167B2 (en) * 2005-10-11 2009-09-29 Blanchette Rockefeller Neurosciences Institute Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratio
US20090029873A1 (en) * 2005-10-11 2009-01-29 Blanchette Rockefeller Neurosciences Institute Alzheimer's Disease-Specific Alterations of the Erk1/Erk2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)
CN101848726A (zh) 2007-02-09 2010-09-29 布朗歇特洛克菲勒神经科学研究所 苔藓抑素、苔藓抑素类似物和其它相关物质对头部创伤引起的记忆缺陷和脑损伤的疗效

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107050A (en) * 1993-05-03 2000-08-22 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic test for alzheimers disease
CN1795158A (zh) * 2003-05-30 2006-06-28 因德纳有限公司 可用于治疗阿尔茨海默病的化合物和含有它们的制剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FAVIT A ET AL.: "PKC isoenzymes are differentially affected by low concentrations of soluble beta-amyloid protein in Alzheimer"s disease", 《SOCIETY FOR NEUROSCIENCE ABSTRACTS》 *
FAVIZ A ET AL.: "Alzheimer’s-specific effects of soluble β-amyloid on protein kinase C-α and -γ degradation in human fibroblasts", 《PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115078570A (zh) * 2022-05-30 2022-09-20 郑州大学第一附属医院 Tau蛋白639位硫氰酸氨基酸修饰在快速质谱法检测阿尔茨海默症中的应用
CN115078570B (zh) * 2022-05-30 2024-05-28 郑州大学第一附属医院 Tau蛋白639位硫氰酸氨基酸修饰在快速质谱法检测阿尔茨海默症中的应用

Also Published As

Publication number Publication date
WO2011041670A2 (en) 2011-04-07
EP2483695A2 (en) 2012-08-08
JP2016197112A (ja) 2016-11-24
JP6013184B2 (ja) 2016-10-25
WO2011041670A3 (en) 2011-06-30
CA2776498A1 (en) 2011-04-07
JP2013506844A (ja) 2013-02-28
US20110212474A1 (en) 2011-09-01
BR112012007557A2 (pt) 2017-05-02

Similar Documents

Publication Publication Date Title
Lian et al. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex
US6495335B2 (en) Compositions and methods for diagnosing alzheimer's disease
Guadagna et al. Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia
ES2412268T3 (es) Alteraciones específicas de la Enfermedad de Alzheimer de la relación de fosforilación ERK1/ERK2 como biomarcadores moleculares específicos de la Enfermedad de Alzheimer (ADSMB)
US20210270847A1 (en) Protein and peptide biomarkers for traumatic injury to the central nervous system
EP2591367B1 (en) Method for diagnosis
JP2016197112A (ja) アルツハイマー病末梢細胞におけるpkcアイソザイムプロセッシングの異常変化
Benussi et al. Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts
Völgyi et al. Mitochondrial proteome changes correlating with β-amyloid accumulation
KR20190110927A (ko) 퇴행성 신경질환 진단용 조성물
JP2008520203A (ja) アルツハイマー病の診断および治療のためのホスファターゼ2a(pp2a)の異常
US20180161432A1 (en) Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
US20080076140A1 (en) Biomarkers of Alzheimer's Disease
Racchi et al. Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease
Bhagavan et al. Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator
JP2011516883A (ja) Erk1/erk2のリン酸化比のアルツハイマー病特異的な変化―アルツハイマー病に特異的な分子バイオマーカー(adsmb)
RU2741227C1 (ru) Способ диагностики черепно-мозговой травмы с использованием белковых биомаркеров
RU2538644C1 (ru) Способ прогнозирования развития острого панкреатита после операций на органах брюшной полости
Alagendran et al. Chromogranin A in human saliva as putative biomarker of alzheimer’s type dementia
WO2026055173A1 (en) Stabilized circulating peptides and uses thereof
Alamri Clinical and synaptosomal studies of cannabinoid receptor 1 and presynaptic proteins in the elderly
Foulds A Study of α-Synuclein, Parkin and TDP-43; Proteins Implicated in Neurodegenerative Disease
Chen et al. P4-166 Overexpression of CDK-5 induces hyperphosphorylation of cytoskeletal proteins and impairment of axonal transport in N2A cells
KR20070084247A (ko) 알츠하이머 질환의 진단 및 치료를 위한 포스파타제 2a(pp2a)의 비정상

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121017